Patents by Inventor Martin Haberey

Martin Haberey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040147535
    Abstract: VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridinamides, their production and use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, as well as intermediate products for the production of the compounds are described. The compounds according to the invention can be used as or in the case of tumor or metastasis growth, psoriasis, Kaposi's sarcoma, restenosis, such as, e.g.
    Type: Application
    Filed: July 31, 2003
    Publication date: July 29, 2004
    Inventors: Andreas Huth, Ludwig Zorn, Martin Kruger, Stuart Ince, Karl-Heinz Thierauch, Andreas Menrad, Martin Haberey, Holger Hess-Stumpp
  • Publication number: 20040147449
    Abstract: The present invention describes the combination of substances interfering with the biological activity of Vascular Endothelial Growth Factor (VEGF)/VEGF receptor systems (compound I) and substances interfering with the biological function of Angiopoietin/Tie receptor systems (compound II) for inhibition of vascularization and for cancer treatment.
    Type: Application
    Filed: March 10, 2004
    Publication date: July 29, 2004
    Inventors: Gerhard Siemeister, Martin Haberey, Karl-Heinz Thierauch
  • Patent number: 6747046
    Abstract: Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production, as well as intermediate products for their production, and the use as pharmaceutical agents for treating various diseases are described.
    Type: Grant
    Filed: September 25, 2002
    Date of Patent: June 8, 2004
    Assignee: Schering Aktiengesellschaft
    Inventors: Martin Krüger, Olaf Prien, Andreas Steinmeyer, Jörg Kroll, Alexander Ernst, Gerhard Siemeister, Martin Haberey, Jens Hoffmann
  • Publication number: 20040102441
    Abstract: Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.
    Type: Application
    Filed: June 24, 2003
    Publication date: May 27, 2004
    Inventors: Martin Krueger, Andreas Huth, Orlin Petrov, Dieter Seidelmann, Karl-Heinz Thierauch, Martin Haberey, Andreas Menrad, Alexander Ernst
  • Publication number: 20040039019
    Abstract: Selected anthranilamide pyridinamines of general formula I 1
    Type: Application
    Filed: June 19, 2003
    Publication date: February 26, 2004
    Applicant: Schering AG
    Inventors: Andreas Huth, Martin Krueger, Ludwig Zorn, Stuart Ince, Karl-Heinz Thierauch, Andreas Menrad, Martin Haberey, Holger Hess-Stumpp
  • Publication number: 20040029880
    Abstract: Substituted anthranilamides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis as well as their intermediate products for the production of anthranilamides are described.
    Type: Application
    Filed: June 23, 2003
    Publication date: February 12, 2004
    Inventors: Martin Krueger, Andreas Huth, Orlin Petrov, Dieter Seidelmann, Karl-Heinz Thierauch, Martin Haberey, Andreas Menrad, Alexander Ernst
  • Publication number: 20030212121
    Abstract: Substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, their production, as well as intermediate products for their production, and the use as pharmaceutical agents for treating various diseases are described.
    Type: Application
    Filed: September 25, 2002
    Publication date: November 13, 2003
    Inventors: Martin Kruger, Olaf Prien, Andreas Steinmeyer, Jorg Kroll, Alexander Ernst, Gerhard Siemeister, Martin Haberey, Jens Hoffman
  • Patent number: 6642218
    Abstract: The invention relates to vitamin D derivatives of formula (I), processes for the production thereof and uses thereof: wherein Y1, Y2, R1-R6, Q and Z are as defined herein.
    Type: Grant
    Filed: December 11, 1998
    Date of Patent: November 4, 2003
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Gerald Kirsch, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich
  • Publication number: 20030176469
    Abstract: The invention relates to substituted anthranylalkyl and cycloalkyl amides of general formula (I) and to their use as medicaments for treating diseases caused by persistent angiogenesis.
    Type: Application
    Filed: May 9, 2003
    Publication date: September 18, 2003
    Inventors: Dieter Seidelmann, Martin Kruger, Eckhard Ottow, Andreas Huth, Karl-heinz Thierauch, Andreas Menrad, Martin Haberey
  • Patent number: 6613920
    Abstract: The invention relates to vitamin D derivatives of formula (I), processes for the production thereof and uses thereof: wherein Y1, Y2, R1—R6, Q and Z are as defined herein.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: September 2, 2003
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Gerald Kirsch, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich
  • Publication number: 20030149006
    Abstract: The invention relates to vitamin D derivatives of general formula I, 1
    Type: Application
    Filed: November 26, 2002
    Publication date: August 7, 2003
    Inventors: Andreas Steinmeyer, Katica Schwarz, Claudia Giesen, Martin Haberey, Marianne Fahnrich
  • Patent number: 6603031
    Abstract: The invention relates to vitamin D derivatives of general formula I, process for their production, intermediate products of the process as well as the use for the production of pharmaceutical agents.
    Type: Grant
    Filed: July 24, 2000
    Date of Patent: August 5, 2003
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Katica Schwarz, Claudia Giesen, Martin Haberey, Marianne Fähnrich
  • Patent number: 6600058
    Abstract: The invention concerns new vitamin D derivatives of general formula (I) a process for their production, their use for production of medicaments, and intermediate products used in the process.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: July 29, 2003
    Assignee: Schering Aktiengellschaft
    Inventors: Andreas Steinmeyer, Gerald Kirsch, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich
  • Publication number: 20030064992
    Abstract: 1
    Type: Application
    Filed: June 26, 2002
    Publication date: April 3, 2003
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jurgen Mestan, Andreas Huth, Martin Kruger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Publication number: 20030055006
    Abstract: The present invention describes the combination of substances interfering with the biological activity of Vascular Endothelial Growth Factor (VEGF)/VEGF receptor systems (compound I) and substances interfering with the biological function of Angiopoietin/Tie receptor systems (compound II) for inhibition of vascularization and for cancer treatment.
    Type: Application
    Filed: June 25, 2001
    Publication date: March 20, 2003
    Applicant: Schering Aktiengesellschaft
    Inventors: Gerhard Siemeister, Martin Haberey, Karl-Heinz Thierauch
  • Patent number: 6531459
    Abstract: Described are new vitamin D derivatives such as of the formula (I) detailed in this disclosure. Also described are methods for preparing these derivatives, inter mediates used to prepare the derivatives and use of the derivatives as pharmaceutical agents.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: March 11, 2003
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Steinmeyer, Günter Neef, Gerald Kirsch, Katica Schwarz, Herbert Wiesinger, Martin Haberey, Marianne Fähnrich, Gernot Langer
  • Publication number: 20030018194
    Abstract: The invention relates to new vitamin D derivatives of general formula (I), process for their production, intermediate products of the process as well as the use for production of pharmaceutical agents.
    Type: Application
    Filed: August 8, 2002
    Publication date: January 23, 2003
    Inventors: Andreas Steinmeyer, Gunter Neef, Gerald Kirsch, Kauca Schwarz, Herbert Wiesinger, Martin Haberey, Marianne Fahnrich, Gernot Langer
  • Patent number: 6448277
    Abstract: Described are compounds of formula (I), wherein W is O or S; X is NR8; Y is CR9R10—(CH2)n wherein R9 and R10 are independently of each other hydrogen or lower alkyl, and n is an integer of from and including 0 to and including 3; or Y is S02; R1 is aryl; R2 is a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms with the exception that R2 cannot represent 2-phthalimidyl, and in case of Y=SO2 cannot represent 2,1,3-benzothiadiazol-4-yl; any of R3, R4, R5 and R6, independently of the other, is H or a substituent other than hydrogen; and R7 and R8, independently of each other, are H or lower alkyl; or a N-oxide or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical product for the treatment of a neoplastic disease which responds to an inhibition of the VEGF receptor tyrosine kinase activity. The compounds of formula (I) can be used for the treatment e.g.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: September 10, 2002
    Assignees: Novartis AG, Schering Aktiengesellschaft
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jürgen Mestan, Andreas Huth, Martin Krüger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Publication number: 20020049344
    Abstract: The invention concerns new vitamin D derivatives of general formula (I) a process for their production, their use for production of medicaments, and intermediate products used in the process.
    Type: Application
    Filed: December 11, 1998
    Publication date: April 25, 2002
    Inventors: ANDREAS STEINMEYER, GERALD KIRSCH, GUNTER NEFF, KATICA SCHWARZ, RUTH THIEROFF-EKERDT, HERBERT WIESINGER, MARTIN HABEREY, MARIANNE FAHNRICH
  • Patent number: 6376480
    Abstract: A method of preparing a pharmaceutical composition, comprising combining a pharmaceutically compatible vehicle with a compound according to formula (I)
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: April 23, 2002
    Assignee: Schering Aktiengesellschaft
    Inventors: Gerald Kirsch, Andreas Steinmeyer, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Andreas Menrad, Martin Haberey